Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 10/20 | 0.47 |
| ▸ | CA12 | O43570 | 9/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 6/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.47 |
| ▸ | HPGD | P15428 | 5/20 | 0.47 |
| ▸ | ACHE | P22303 | 5/20 | 0.47 |
| ▸ | GAA | P10253 | 4/20 | 0.47 |
| ▸ | AKR1B1 | P15121 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | GLA | P06280 | 2/20 | 0.47 |
| ▸ | CASP1 | P29466 | 2/20 | 0.47 |
| ▸ | CASP7 | P55210 | 2/20 | 0.47 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9464450 | 0.74 | KDM4E (0.54) | CA9CA12MCL1HSD17B10ALDH1A1 | |
| Coumarin SCHEMBL7633181 | 0.74 | CA12 (0.62) | CA9CA12MCL1HSD17B10ALDH1A1 | |
| SCHEMBL23303231 | 0.71 | GAA (0.47) | CA9CA12MCL1HSD17B10ALDH1A1 | |
| SCHEMBL17037877 | 0.70 | CA9 (0.41) | CA9CA12MCL1HSD17B10ALDH1A1 | |
| SCHEMBL5579338 | 0.68 | KDM4E (0.50) | CA9CA12MCL1HSD17B10ALDH1A1 | |
| SCHEMBL23845864 | 0.67 | GAA (0.38) | CA9CA12MCL1HSD17B10ALDH1A1 | |
| SCHEMBL12608748 | 0.67 | MAOA (0.55) | HSD17B10ALDH1A1KDM4EHPGDMAPT | |
| SCHEMBL5539713 | 0.66 | CA12 (0.61) | CA9CA12MCL1HSD17B10ALDH1A1 | |
| SCHEMBL395756 | 0.66 | MEN1 (0.40) | CA9HSD17B10ALDH1A1CYP3A4CYP1A2 | |
| SCHEMBL9442055 | 0.66 | CA1 (0.31) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220401379-A1 | BAKUCHIOL COMPOSITIONS FOR TREATMENT OF POST INFLAMMATORY HYPERPIGMENTATION | UNIGEN, INC. (US) | 2022-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220401379-A1 | BAKUCHIOL COMPOSITIONS FOR TREATMENT OF POST INFLAMMATORY HYPERPIGMENTATION | CFH, MPO, TYR | CA9 3247/4885CA12 4742/4885MCL1 1490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.